Plain-English translation of NCT06058182 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand why some patients recover well after a heart attack while others develop lasting heart weakness. This study collects blood samples from patients who have experienced acute coronary syndrome (a sudden blockage in heart arteries) and have received percutaneous coronary intervention—a procedure to restore blood flow. By analyzing genetic material in the blood, the team hopes to identify markers that can predict which patients are at risk for weakened heart function.
After a heart attack, some patients develop a serious condition called ventricular dysfunction, where the heart's pumping ability is permanently weakened. Currently, doctors cannot reliably predict which patients will develop this complication. This study aims to discover blood-based genetic markers that could warn doctors early about who is at highest risk, potentially leading to better monitoring and treatment strategies.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be asked to donate blood samples at specific time points after your heart attack treatment. The research team will analyze genetic material in your blood to look for patterns associated with heart recovery or weakness. The study is observational, meaning researchers will follow your medical course and outcomes without giving you any experimental medication—they are simply monitoring your condition and collecting blood samples to understand the biology of heart recovery.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
Italy
Sponsor
IRCCS Policlinico S. Donato
Enrollment target
~70 participants
Started
July 2020
Primary completion
January 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Luca Testa
IRCCS Policlinico S. Donato
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.